SCHEMBL25530573

SCHEMBL25530573

COc1cc(C(C)(C)C)ccc1CN(C)C(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.49
CYP1A2 P05177 1/20 0.49
KDM4E B2RXH2 1/20 0.40
NR1H4 Q96RI1 2/20 0.39
PYCR1 P32322 1/20 0.39
HTT P42858 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
CETP P11597 1/20 0.36
CYP2D6 P10635 1/20 0.36
HTR2A P28223 2/20 0.35
SLC6A4 P31645 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25536711 0.84 CYP1A2 (0.46) CYP2C19CYP1A2KDM4ENR1H4PYCR1
SCHEMBL25563236 0.83 CYP1A2 (0.45) CYP2C19CYP1A2KDM4ENR1H4PYCR1
SCHEMBL25530577 0.83 CYP1A2 (0.41) CYP2C19CYP1A2KDM4ENR1H4PYCR1
SCHEMBL12454184 0.81 APLNR (0.54) KDM4EHTTMEN1KMT2AGAA
SCHEMBL25530593 0.81 CYP2C19 (0.53) CYP2C19CYP1A2KDM4ENR1H4PYCR1
SCHEMBL9782933 0.79 NR1H4 (0.46) CYP2C19CYP1A2NR1H4HTTMEN1
SCHEMBL3624549 0.79 HTR2A (0.51) CYP2C19CYP1A2KDM4EHTR2AKCNH2
SCHEMBL25530589 0.78 CYP2C19 (0.50) CYP2C19CYP1A2KDM4ENR1H4PYCR1
SCHEMBL25530592 0.78 CYP2C19 (0.50) CYP2C19CYP1A2KDM4ENR1H4PYCR1
SCHEMBL4623834 0.77 HTR2A (0.45) CYP2C19CYP1A2NR1H4HTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159491-A1 Antimicrobial Compounds and Methods NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159491-A1 Antimicrobial Compounds and Methods MPO, NISCH, RPN2 CYP2C19 2355/4885CYP1A2 3539/4885KDM4E 3027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.